MedPacto Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Selling, General & Admin	4,254	4,427	5,021	4,607	3,535
Research & Development	24,263	24,164	31,919	24,551	23,962
Other Operating Expenses	-	-	-	12.46	13.91
Operating Expenses	28,665	28,752	37,246	29,459	27,800
Operating Income	-28,665	-28,752	-37,246	-29,459	-27,800
Interest Expense	-87.63	-493.23	-9,621	-7,769	-31.27
Interest & Investment Income	1,048	388.46	1,324	663.52	508.79
Earnings From Equity Investments	-	-	-	-	-248.59
Currency Exchange Gain (Loss)	-39.28	114.09	25.05	-19.66	-146.41
Other Non Operating Income (Expenses)	57.34	64.07	9,272	19,278	151.9
EBT Excluding Unusual Items	-27,687	-28,679	-36,246	-17,306	-27,566
Gain (Loss) on Sale of Investments	-58.51	-39.93	492.28	266.33	2,213
Gain (Loss) on Sale of Assets	-5.93	-5.93	-	-	-
Other Unusual Items	-	-6,600	-	-	-
Pretax Income	-27,751	-35,325	-35,753	-17,040	-25,352
Net Income	-27,751	-35,325	-35,753	-17,040	-25,352
Net Income to Common	-27,751	-35,325	-35,753	-17,040	-25,352
Shares Outstanding (Basic)	27	21	33	20	20
Shares Outstanding (Diluted)	27	21	33	20	20
Shares Change (YoY)	-17.66%	-36.20%	62.45%	0.88%	-
EPS (Basic)	-1010.14	-1664.87	-1075.00	-832.30	-1249.24
EPS (Diluted)	-1010.14	-1664.87	-1075.00	-832.30	-1249.24
Free Cash Flow	-25,192	-26,402	-30,491	-25,909	-24,100
Free Cash Flow Per Share	-916.99	-1244.33	-916.79	-1265.52	-1187.53
EBITDA	-26,970	-26,919	-35,380	-27,736	-26,363
D&A For EBITDA	1,695	1,833	1,866	1,723	1,437
EBIT	-28,665	-28,752	-37,246	-29,459	-27,800

Source: S&P Capital IQ. Standard template. Financial Sources.